Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

ClinicalTrials.gov ID: NCT02504216

Public ClinicalTrials.gov record NCT02504216. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 11:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An International, Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Trial Investigating the Efficacy and Safety of Rivaroxaban to Reduce the Risk of Major Thrombotic Vascular Events in Patients With Symptomatic Peripheral Artery Disease Undergoing Lower Extremity Revascularization Procedures

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of study was to test whether rivaroxaban added to standard of care treatment, when compared to placebo, had the potential to reduce the incidence of the clinical events related to the clots and complications of the heart and brain (CV death, MI, or stroke) or the legs (acute limb ischemia or major amputation) in patients who had undergone recent procedure(s) to improve the blood flow of their legs.

Study identification

NCT ID
NCT02504216
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
6,564 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 18, 2015 (Actual)
Primary completion
Nov 27, 2019 (Actual)
Completion
Jan 9, 2020 (Actual)
Last update posted
Dec 8, 2020

2015 – 2020

United States locations

U.S. sites
105
U.S. states
32
U.S. cities
94
Facility City State ZIP Site status
Not listed Alexander City Alabama 35010 —
Not listed Birmingham Alabama 35294-0012 —
Not listed Fort Payne Alabama 35967 —
Not listed Huntsville Alabama 35801-4317 —
Not listed Avondale Arizona 85388 —
Not listed Glendale Arizona 85340 —
Not listed Phoenix Arizona 85006 —
Not listed Mission Viejo California 92691 —
Not listed Northridge California 91325 —
Not listed Palo Alto California 94304 —
Not listed Roseville California 95661 —
Not listed Stanford California 94305 —
Not listed Torrance California 90502 —
Not listed Aurora Colorado 80045 —
Not listed Denver Colorado 80220 —
Not listed Washington D.C. District of Columbia 20007 —
Not listed Washington D.C. District of Columbia 20422 —
Not listed Atlantis Florida 33462 —
Not listed Clearwater Florida 33756 —
Not listed Daytona Beach Florida 32117 —
Not listed Gainesville Florida 32605 —
Not listed Hudson Florida 34667 —
Not listed Jacksonville Florida 32209 —
Not listed Jacksonville Florida 32216 —
Not listed Miami Florida 33173 —
Not listed Ocala Florida 34474 —
Not listed Pensacola Florida 32501 —
Not listed Safety Harbor Florida 34695 —
Not listed Tallahassee Florida 32308 —
Not listed Wellington Florida 33449 —
Not listed Arlington Heights Illinois 60005 —
Not listed Elk Grove Village Illinois 60007 —
Not listed Springfield Illinois 62701 —
Not listed Springfield Illinois 62702 —
Not listed Urbana Illinois 61801 —
Not listed Fort Wayne Indiana 46804 —
Not listed Fort Wayne Indiana 46845 —
Not listed Merrillville Indiana 46410 —
Not listed Iowa City Iowa 52242 —
Not listed Lexington Kentucky 40536 —
Not listed Alexandria Louisiana 71301 —
Not listed Covington Louisiana 70433 —
Not listed Shreveport Louisiana 71103 —
Not listed Shreveport Louisiana 71105 —
Not listed Lewiston Maine 04240 —
Not listed Baltimore Maryland 21201-1595 —
Not listed Baltimore Maryland 21218 —
Not listed Clinton Maryland 20735 —
Not listed Bay City Michigan 48708 —
Not listed Dearborn Michigan 48126 —
Not listed Detroit Michigan 48201 —
Not listed Lansing Michigan 48912 —
Not listed Midland Michigan 48670 —
Not listed Muskegon Michigan 49444 —
Not listed Wyoming Michigan 49519 —
Not listed Coon Rapids Minnesota 55433 —
Not listed Saint Cloud Minnesota 56303 —
Not listed Jackson Mississippi 39216 —
Not listed Tupelo Mississippi 38801 —
Not listed Springfield Missouri 65807 —
Not listed St Louis Missouri 63128 —
Not listed Lincoln Nebraska 68506 —
Not listed Lincoln Nebraska 68510 —
Not listed Lebanon New Hampshire 03756-0001 —
Not listed Flemington New Jersey 08822 —
Not listed Linden New Jersey 07036 —
Not listed Teaneck New Jersey 07666 —
Not listed New York New York 10011 —
Not listed New York New York 10029 —
Not listed Saratoga Springs New York 12866 —
Not listed Chapel Hill North Carolina 27517 —
Not listed Charlotte North Carolina 28204 —
Not listed Durham North Carolina 27710 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Minot North Dakota 58701 —
Not listed Cincinnati Ohio 45219 —
Not listed Cincinnati Ohio 45267 —
Not listed Dayton Ohio 45414 —
Not listed Springfield Ohio 45505 —
Not listed Toledo Ohio 43614 —
Not listed Oklahoma City Oklahoma 73135 —
Not listed Hillsboro Oregon 97123 —
Not listed Camp Hill Pennsylvania 17011 —
Not listed Erie Pennsylvania 16507 —
Not listed Philadelphia Pennsylvania 19104 —
Not listed Philadelphia Pennsylvania 19140 —
Not listed York Pennsylvania 17405 —
Not listed Greenville South Carolina 29657 —
Not listed Rapid City South Dakota 57702 —
Not listed Knoxville Tennessee 37934 —
Not listed Amarillo Texas 79106 —
Not listed Austin Texas 78705 —
Not listed Dallas Texas 75216-7167 —
Not listed Dallas Texas 75226 —
Not listed Edinburg Texas 78539 —
Not listed Houston Texas 77030 —
Not listed Humble Texas 77338 —
Not listed Huntsville Texas 77340 —
Not listed Kingwood Texas 77339 —
Not listed San Antonio Texas 78258 —
Not listed Tyler Texas 75701 —
Not listed Victoria Texas 77901 —
Not listed Madison Wisconsin 53713 —
Not listed Manitowoc Wisconsin 54220 —
Not listed Wausau Wisconsin 54401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 427 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02504216, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 8, 2020 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02504216 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →